ANIK NASDAQ
Anika Therapeutics, Inc.
1W: -2.1%
1M: -3.4%
3M: +41.3%
YTD: +60.6%
1Y: +25.6%
3Y: -41.0%
5Y: -65.6%
$14.88
-0.14 (-0.93%)
Weekly Expected Move ±14.8%
$11
$13
$15
$17
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$116M
Revenue
+23.2% YoY
$-11M
Net Income
+80.5% YoY
$1M
Free Cash Flow
+126.3% YoY
64.2%
Gross Margin
-18.5%
Op. Margin
-17.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-7.4%
ROA-5.6%
ROIC-8.8%
Valuation
P/E-18.2
P/B1.5
EV/EBITDA-28.5
Leverage
Debt/Equity0.17
Current Ratio4.72
Interest Cov.0.0x
Quality Scores
Piotroski F6/9
Altman Z3.89
Beneish M-3.06